Trials / Terminated
TerminatedNCT01723397
Effect of Nasaleze on Nasal Challenge With Allergen
Effect of Nasaleze on the Early Reaction to Nasal Challenge With Allergen
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 14 (actual)
- Sponsor
- University of Chicago · Academic / Other
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objectives of this protocol are: 1. to confirm the inhibitory effect of Nasaleze on the immediate response to nasal challenge with antigen, and 2. to show that inhibition of the immediate response to nasal challenge with antigen by Nasaleze inhibits subsequent inflammatory events.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nasaleze Spray | Subjects are treated with over the counter Nasaleze cellulose powder nasal spray then challenged with allergen |
| OTHER | Placebo spray | Subjects are treated with placebo nasal spray then challenged with allergen |
| BIOLOGICAL | Allergen | Subjects are challenged with grass or ragweed allergen after treatment with Nasaleze or placebo |
Timeline
- Start date
- 2012-11-01
- Primary completion
- 2014-07-01
- Completion
- 2014-07-01
- First posted
- 2012-11-07
- Last updated
- 2017-01-02
- Results posted
- 2016-10-27
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01723397. Inclusion in this directory is not an endorsement.